Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine for intractable rosacea
ChiCTR2300073083Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of paroxetine in rosacea (3 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoint: Clinical Erythema Assessment effective improvement rate. Started Jul 2023; status: recruiting.
02
Drugs
paroxetine
03
Conditions
rosacea
Beyond the preview
Go deeper on ChiCTR2300073083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073083.